A Study to Evaluate the Safety and Efficacy of BIIB104 in Participants With Cognitive Impairment Associated With Schizophrenia (CIAS)

Conditions:   Cognitive Impairment Associated With Schizophrenia;   Schizophrenia Interventions:   Drug: BIIB104;   Other: Placebo Sponsor:   Biogen Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials